BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31711890)

  • 21. [Immunoglobulin heavy chain gene rearrangements in the monoclonal gammopathies].
    Bosaleh A; Denninghoff V; Garcia A; Rescia C; Avagnina A; Elsner B
    Medicina (B Aires); 2005; 65(3):219-25. PubMed ID: 16042132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization of Analytical Omics Tools in the Molecular Diagnostics of Multiple Myeloma.
    Kovacs Z; Guttman A
    Curr Mol Med; 2018; 18(4):260-272. PubMed ID: 30295190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma.
    Binder M; Rajkumar SV; Ketterling RP; Dispenzieri A; Lacy MQ; Gertz MA; Buadi FK; Hayman SR; Hwa YL; Zeldenrust SR; Lust JA; Russell SJ; Leung N; Kapoor P; Go RS; Gonsalves WI; Kyle RA; Kumar SK
    Blood Cancer J; 2016 Mar; 6(3):e401. PubMed ID: 26967818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma.
    Rustad EH; Misund K; Bernard E; Coward E; Yellapantula VD; Hultcrantz M; Ho C; Kazandjian D; Korde N; Mailankody S; Keats JJ; Akhlaghi T; Viny AD; Mayman DJ; Carroll K; Patel M; Famulare CA; Op Bruinink DH; Hutt K; Jacobsen A; Huang Y; Miller JE; Maura F; Papaemmanuil E; Waage A; Arcila ME; Landgren O
    Am J Hematol; 2019 Dec; 94(12):1364-1373. PubMed ID: 31571261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas.
    Corradini P; Boccadoro M; Voena C; Pileri A
    J Exp Med; 1993 Sep; 178(3):1091-6. PubMed ID: 8350048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of clonal evolution in smoldering multiple myeloma.
    Bhatnagar V; Badros A
    Leuk Lymphoma; 2014 Feb; 55(2):464-6. PubMed ID: 23865829
    [No Abstract]   [Full Text] [Related]  

  • 27. Next-generation sequencing of peripheral B-lineage cells pinpoints the circulating clonotypic cell pool in multiple myeloma.
    Thiele B; Kloster M; Alawi M; Indenbirken D; Trepel M; Grundhoff A; Binder M
    Blood; 2014 Jun; 123(23):3618-21. PubMed ID: 24753536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delineation of a novel pre-B cell component in plasma cell myeloma: immunochemical, immunophenotypic, genotypic, cytologic, cell culture, and kinetic features.
    Grogan TM; Durie BG; Lomen C; Spier C; Wirt DP; Nagle R; Wilson GS; Richter L; Vela E; Maxey V
    Blood; 1987 Oct; 70(4):932-42. PubMed ID: 3115338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of circulating monoclonal lymphocytes in multiple myeloma patients by analysis of gene rearrangements: correlation with progressive disease.
    Knauf WU; Pochanke G; Ho AD
    Leuk Res; 1993 Apr; 17(4):341-5. PubMed ID: 8487582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mass cytometry analysis shows that a novel memory phenotype B cell is expanded in multiple myeloma.
    Hansmann L; Blum L; Ju CH; Liedtke M; Robinson WH; Davis MM
    Cancer Immunol Res; 2015 Jun; 3(6):650-60. PubMed ID: 25711758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.
    Santonocito AM; Consoli U; Bagnato S; Milone G; Palumbo GA; Di Raimondo F; Stagno F; Guglielmo P; Giustolisi R
    Leuk Res; 2004 May; 28(5):469-77. PubMed ID: 15068900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice.
    Pilarski LM; Seeberger K; Coupland RW; Eshpeter A; Keats JJ; Taylor BJ; Belch AR
    Exp Hematol; 2002 Mar; 30(3):221-8. PubMed ID: 11882359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and Clinical Significance of Neuropilin-1 in Patients With Multiple Myeloma.
    Karczmarczyk A; Bilska S; Korpysz M; Purkot J; GrzĄŚko N; Hus M; Giannopoulos K
    Anticancer Res; 2020 Oct; 40(10):5437-5443. PubMed ID: 32988865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessment.
    Hultcrantz M; Rustad EH; Yellapantula V; Arcila M; Ho C; Syed MH; Papaemmanuil E; Zhang Y; Maura F; Landgren O
    Blood Cancer J; 2020 Jul; 10(7):76. PubMed ID: 32699232
    [No Abstract]   [Full Text] [Related]  

  • 35. [Molecular evidence for a single clonal origin in a patient with multiple myeloma and non-Hodgkin's lymphoma].
    Nagamura F; Goto S; Iseki T; Saotome T; Takeshita A; Kikuno K; Yonemitsu H; Yumoto N; Mikata A; Ohto M
    Rinsho Ketsueki; 1995 Oct; 36(10):1182-7. PubMed ID: 8531328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant bone marrow involvement by plasma cell myeloma and primary myelodysplastic syndrome with biclonal complex chromosome anomalies.
    Nanaji NM; Chen QC; Singh Z; Ross DD; Elman AH; Zou YS
    Leuk Lymphoma; 2015; 56(8):2470-2. PubMed ID: 25586604
    [No Abstract]   [Full Text] [Related]  

  • 37. Intrinsic expression of the multidrug transporter, P-glycoprotein 170, in multiple myeloma: implications for treatment.
    Pilarski LM; Belch AR
    Leuk Lymphoma; 1995 May; 17(5-6):367-74. PubMed ID: 7549827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical applicability and prognostic significance of molecular response assessed by fluorescent-PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/PETHEMA study.
    Martinez-Lopez J; Fernández-Redondo E; García-Sánz R; Montalbán MA; Martínez-Sánchez P; Pavia B; Mateos MV; Rosiñol L; Martín M; Ayala R; Martínez R; Blanchard MJ; Alegre A; Besalduch J; Bargay J; Hernandez MT; Sarasquete ME; Sanchez-Godoy P; Fernández M; Blade J; San Miguel JF; Lahuerta JJ;
    Br J Haematol; 2013 Dec; 163(5):581-9. PubMed ID: 24117042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incomplete DJH rearrangements.
    González D; Garcia-Sanz R
    Methods Mol Med; 2005; 113():165-73. PubMed ID: 15968101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exome sequencing in tracking clonal evolution in multiple myeloma following therapy.
    Weston-Bell N; Gibson J; John M; Ennis S; Pfeifer S; Cezard T; Ludwig H; Collins A; Zojer N; Sahota SS
    Leukemia; 2013 Apr; 27(5):1188-91. PubMed ID: 23147253
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.